Tag - SGLT2 inhibitors

  • Home
  • Tag -
  • SGLT2 inhibitors

Explore the Latest ISN Global Trials Focus Selections Featuring a “Trial of the Month” on the Effects of Semaglutide on CKD in People With Type 2 Diabetes

ISN-ACT Global Trials Focus editorial team member Michele Provenzano summarizes the design and outcomes of the latest "Trial of the Month" featured in ISN-ACT Global Trials Focus. The "Trial of the Month" is available in several languages, now including German. Read all global trial selections from the ISN-ACT initiative here. In addition, in the ISN 'Guide for Everyone' series,...

September 2, 2024News, ResearchRead more...

Hear From Global Experts on Equitable Access to Innovative Therapies

Aligning with the 2024 World Kidney Day theme, "Advancing equitable access to care and optimal medication practice," Nature Reviews Nephrology has published an editorial on innovative therapies for diabetic kidney disease (DKD). Five global experts* from different world regions, including authors of the 2024 World Kidney Day scientific editorial, discuss barriers that must be...

July 15, 2024Advocacy, Research, World Kidney DayRead more...

Advancing Knowledge on CKD Treatment and Prevention: The ISN Supports Scientific Meeting in Macedonia

Delegates enjoy the program In April, the ISN supported the "7th Congress of the Macedonian Society of Nephrology, Dialysis and Artificial Organs (MSNDTAO) With International Participation" in Skopje, Macedonia, through its Continuing Medical Education Program (CME). The scientific program included an ISN CME course, "From Prevention to Best Treatment Options in CKD." Dr. Goce Spasovski presents on...

May 21, 2024CME, Grants, NewsRead more...

Explore the ISN Global Trials Focus Selection for February and March, Featuring a “Trial of the Month” on the Efficacy and Safety of Aldosterone Synthase Inhibition 

ISN-ACT Global Trials Focus editorial team member Neeru Agarwal summarizes the design and outcomes of the latest ISN-ACT Global Trials Focus "Trial of the Month."  The "Trial of the Month" is available in several languages, now including German. Read all global trial selections from the ISN-ACT initiative here. In addition, selected clinical trials are demystified for the layperson.  Part of the...

April 23, 2024News, ResearchRead more...

ISN-Endorsed Events With ISN Participation in April – Apply for ISN Endorsement for Your Event!

The ISN endorses high-quality events within the kidney care community. Whether your event is big or small, if it addresses region-relevant topics, it could qualify for our endorsement. Apply for ISN endorsement for enhanced visibility, scientific merit, and educational impact. Discover all the benefits of ISN-endorsed meetings and how to apply here April 25-28, 2024               Jakarta,...

April 2, 2024ISN Participates, NewsRead more...

Beyond Blood Sugar: Ele Ferrannini on the Basis for the Transformative Power of SGLT2 Inhibitors for Kidney Disease Management at WCN’24

Ele Ferrannini, a professor of Internal Medicine at the University of Pisa and a senior research associate at the National Research Council Institute of Clinical Physiology, will present the plenary talk "Insights Into SGLT2 Inhibitors: A Story of Discovery" at WCN'24 in Hall A on Tuesday, April 16 at 11 a.m. Argentina time. Register for...

December 11, 2023News, WCNRead more...